These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 12504005)
1. B cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-kappaB regulated c-myc transcription. Grumont RJ; Strasser A; Gerondakis S Mol Cell; 2002 Dec; 10(6):1283-94. PubMed ID: 12504005 [TBL] [Abstract][Full Text] [Related]
2. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. Grumont RJ; Rourke IJ; O'Reilly LA; Strasser A; Miyake K; Sha W; Gerondakis S J Exp Med; 1998 Mar; 187(5):663-74. PubMed ID: 9480976 [TBL] [Abstract][Full Text] [Related]
3. The mitogen-induced increase in T cell size involves PKC and NFAT activation of Rel/NF-kappaB-dependent c-myc expression. Grumont R; Lock P; Mollinari M; Shannon FM; Moore A; Gerondakis S Immunity; 2004 Jul; 21(1):19-30. PubMed ID: 15345217 [TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways. Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392 [TBL] [Abstract][Full Text] [Related]
6. Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis. Campbell IK; Gerondakis S; O'Donnell K; Wicks IP J Clin Invest; 2000 Jun; 105(12):1799-806. PubMed ID: 10862795 [TBL] [Abstract][Full Text] [Related]
7. TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha. Arsura M; Wu M; Sonenshein GE Immunity; 1996 Jul; 5(1):31-40. PubMed ID: 8758892 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of type I diabetes by NF-kappa B. Lamhamedi-Cherradi SE; Zheng S; Hilliard BA; Xu L; Sun J; Alsheadat S; Liou HC; Chen YH J Immunol; 2003 Nov; 171(9):4886-92. PubMed ID: 14568969 [TBL] [Abstract][Full Text] [Related]
9. Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways. Zarnegar B; He JQ; Oganesyan G; Hoffmann A; Baltimore D; Cheng G Proc Natl Acad Sci U S A; 2004 May; 101(21):8108-13. PubMed ID: 15148378 [TBL] [Abstract][Full Text] [Related]
10. CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB. Neumann M; Wohlleben G; Chuvpilo S; Kistler B; Wirth T; Serfling E; Schimpl A J Immunol; 1996 Dec; 157(11):4862-9. PubMed ID: 8943389 [TBL] [Abstract][Full Text] [Related]
12. NF-kappaB/p50 and NF-kappaB/c-Rel differentially regulate the activity of the 3'alphaE-hsl,2 enhancer in normal murine B cells in an activation-dependent manner. Zelazowski P; Shen Y; Snapper CM Int Immunol; 2000 Aug; 12(8):1167-72. PubMed ID: 10917891 [TBL] [Abstract][Full Text] [Related]
13. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. Lee H; Arsura M; Wu M; Duyao M; Buckler AJ; Sonenshein GE J Exp Med; 1995 Mar; 181(3):1169-77. PubMed ID: 7869034 [TBL] [Abstract][Full Text] [Related]
14. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727 [TBL] [Abstract][Full Text] [Related]
15. Maintenance of nuclear factor-kappa B/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of I kappa B proteins. Schauer SL; Wang Z; Sonenshein GE; Rothstein TL J Immunol; 1996 Jul; 157(1):81-6. PubMed ID: 8683159 [TBL] [Abstract][Full Text] [Related]
16. c-Rel regulation of the cell cycle in primary mouse B lymphocytes. Hsia CY; Cheng S; Owyang AM; Dowdy SF; Liou HC Int Immunol; 2002 Aug; 14(8):905-16. PubMed ID: 12147627 [TBL] [Abstract][Full Text] [Related]
17. LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice. Thornburg NJ; Kulwichit W; Edwards RH; Shair KH; Bendt KM; Raab-Traub N Oncogene; 2006 Jan; 25(2):288-97. PubMed ID: 16247482 [TBL] [Abstract][Full Text] [Related]
18. The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells. Pohl T; Gugasyan R; Grumont RJ; Strasser A; Metcalf D; Tarlinton D; Sha W; Baltimore D; Gerondakis S Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4514-9. PubMed ID: 11930006 [TBL] [Abstract][Full Text] [Related]
19. Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinase. Jeay S; Sonenshein GE; Kelly PA; Postel-Vinay MC; Baixeras E Endocrinology; 2001 Jan; 142(1):147-56. PubMed ID: 11145577 [TBL] [Abstract][Full Text] [Related]
20. Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB. Grumont RJ; Gerondakis S J Exp Med; 2000 Apr; 191(8):1281-92. PubMed ID: 10770796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]